Investigating biomarkers of Staphylococcus aureus bacteremia in patients - School of Pharmacy
Por um escritor misterioso
Descrição
The Centers for Disease Control identifies methicillin-resistant S. aureus (MRSA) as a serious health threat with greater than 100,000 invasive infections and 20,000 patient deaths annually in the United States. Despite recent advancements in available treatment options for methicillin-sensitive S.
Current Paradigms of Combination Therapy in Methicillin-Resistant Staphylococcus aureus (MRSA) Bacteremia: Does it Work, Which Combination, and For Which Patients? - Abstract - Europe PMC
PDF) Nasopharyngeal and Oropharyngeal Colonization by Staphylococcus aureus and Streptococcus pneumoniae and Prognostic Markers in Children with Sickle Cell Disease from the Northeast of Brazil
The Golden Grapes of Wrath – Staphylococcus aureus Bacteremia: A Clinical Review - The American Journal of Medicine
School of Pharmacy and Pharmaceutical Sciences 2020-21 Annual Report by BinghamtonU - Issuu
Frontiers Clinical Characteristics of Bloodstream Infection in Immunosuppressed Patients: A 5-Year Retrospective Cohort Study
Methicillin-resistant Staphylococcus aureus: novel treatment approach breakthroughs, Bulletin of the National Research Centre
Phenotyping of Methicillin-Resistant Staphylococcus aureus Using a Ratiometric Sensor Array
Examining the clinical impact of rapid multiplex polymerase chain reaction‐based diagnostic testing for bloodstream infections in a national cohort of the Veterans Health Administration - Britt - 2023 - Pharmacotherapy: The Journal
PDF) Application of Nanomaterials in the Prevention, Detection, and Treatment of Methicillin-Resistant Staphylococcus aureus (MRSA)
Implementing a hospital-wide protocol for Staphylococcus aureus bacteremia
Rescuing the Last-Line Polymyxins: Achievements and Challenges
de
por adulto (o preço varia de acordo com o tamanho do grupo)
:max_bytes(150000):strip_icc()/staph-infections-3156887-FINAL2-48c3a7caea8f429a94f7d074e66d5842.png)
